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INTRODUCTION 
GENERAL - The gen(2ral role of Ca-H- as an agent that mediates 
excitation- response coupling has only recently been recognized 
(Berridge, 1975). The study of the biochemistry of Ca++ -mediated 
cellular processes has blossomed following the proposal by Kretsinger 
(1977) that Ca-H- actions are the result of binding to specific 
proteins V\?hich may be considered as Ca-f-t- receptors. 
Calmodulin (CaM) is a ubiquitous and extremely versatile 
Ca++- binding protein ^^ /hich serves to mediate numerous Ca-f-f regulatory 
enzyme systems and cellular processes (Cheung, 1980; Klee et al., 
1980). It has four Ca-H- binding sites per molecule and on binding 
Ca-H-, CaM undergoes conformational changes that enable the Ca-^ -^ -CaM 
complex to bind to and regulate the functions of a number of target 
proteins (Manalan and Klee, 1984). 
CaM was first described by Cheung (1970) as an activator of 
cyclic nucleotide phosphodiesterase. At the same time, Kakiuchi et al. 
(1970) reported the presence of a phosphodiesterase activating factor, 
specific for the Ca-H- -dependent phosphodiesterase in brain . Teo and 
Wang (1973) later demonstrated the identity of the two proteins and 
the Ca-H- -binding property of the factor. 
Although CaM is now the most widely accepted name for 
this protein, it has been referred to as activator protein, modulator 
protein, Ca-H- -dependent regulator protein and troponin-C like protein 
in literature. The diverse nomenclature reflects, in part, the many 
functions now ascribed to CaM. 
CaM is a very low molecular weight protein. Sedimentation 
equilibrium experiments and gel electrophoresis in the presence of SDS 
have given molecular weight values in the range of 15-19 kDa both 
in presence and absence of Ca++ (Lin et al., 1974; Klee et al., 1980). 
Thus, the protein exists as a monomer. CaM is stable to heat and 
acid treatment. It is highly acidic with an isoelectric pH varying 
between 3.9-4.3 (Lin et al., 1974; Dedman et al., 1977; Stevens et 
al., 1976) and perhaps for this reason migrates on gel filtration with 
an anomalously large apparent Stokes' radius. 
DISTRIBUTION - CaM is widely distributed in eukaryotes (Smoake et al., 
1974). Homogeneous preparations of CaM have been obtained from many 
vertebrate tissues (Teo et al., 1973; Klee, 1977; Yazawa et al., 
1978). CaM concentration is highest in brain and testes where 
concentrations of several hundred mg/kg of tissue are found (Watterson 
et al., 1976; Dedman et al., 1977). The richest source of CaM reported 
to date is the electroplax of the electric eel where CaM constitutes 
2% of the total protein (Childers and Siegel, 1975). Waisman et al. 
(1975) first reported the presence of CaM in extracts of tissues from 
several invertebrate sources including sea anemone, clam, snail, earth 
worm, round worm, blue crab and star fish. It has subsequently been 
found in the protozoan Euglena gracilis and Amoeba proteus (Kuznicki 
et al,, 1979). CaM has been purified from yeast cells where it 
controls several cellular activities (Davis et al., 1986). 
The subcellular distribution of CaM has been examined in human 
platelets and rat liver parenchymal cells (Smoake et al., 1974), C-6 
glial tumor cells (Brostrom and Wolff, 1974), porcine brain (Egrie et 
al., 1977), rat brain (Teshima and Kakiuchi, 1978) and rabbit sperm 
(Jones et al., 1978). In glial tumour cells, the particulate CaM 
showed 6,11 and 8% association with the nuclear, mitochondrial and 
microsomal fractions respectively (Brostrom and Wolff,1974). In rabbit 
sperm, it is exclusively associated with the head where it constitutes 
72% of the total soluble proteins (Jones et al., 1978). 
STRUCTURE - CaM consists of 148 amino acids. Tryptophan and cysteine 
are characteristically absent, threonine, serine ratio is high (12:4), 
27 glutamate and 23 aspartate residues are present and the molecule 
has a single residue each of histidine and trimethyl lysine (Watterson 
et al., 1980; Jackson et al., 1977; Miyake and Kakiuchi, 1978). The 
presence of trimethyl lysine is a useful aid in the identification of 
the protein. Tlie absence of tryptophan and the high phenylalanine, 
tyrosine ratio gives CaM a characteristic UV-absorption spectrum. The 
circular dichroic spectra in the far UV is characteristic of a protein 
with high alpha-helix. 
The amino acid sequence of bovine brain CaM is shown in Fig. 1 
(Watterson et al., 1980). The four postulated Ca-H- -binding residues 
and the proposed helical sequences indicated in the figure are based 
on analogy with parvalbumin and troponin C (Kretsinger and Barry, 
1975). According to this model, the structure of the Ca++ -binding 
domains in this family of homologous proteins consists of helical 
regions connected by a loop of 12 amino acid residues with 
appropriately positioned Ca++ -binding residues. The Ca++ -binding 
loops have been shown to consistently contain sequences favourable for 
Figure 1. Amino Acid Sequence of Calmodulin. The sequence 
of bovine brain calmodulin is shoim utilizing 
the one- letter code for amino acid residues. A, 
Ala; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, 
He; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, 
Gin; R, Arg; S, Ser; T, Thr; V, Val; Y, Tyr. The 
four proposed Ca++-binding domains with the 
stretches of alpha helix (darker circles) are 
indicated (Klee et al.", 1980). 
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the formation of beta turns (Vogt et al., 1979). The two tyrosyl 
residues are located in the 3rd and 4th domains. The single trimethyl 
lysine residue occurs between domain 3 and 4 and the single histidyl 
residue is located in the helical region of domain 3. There is 
considerable homology among the four domains in CaM. This homology is 
greater betvv^ een 1 5 3 and 2 & 4 which suggests that CaM may have 
arisen by two successive doublings of a primordial gene coding for a 
Ca++ binding domain (Watterson et al., 1980). 
The sequence data of CaM from various animal species suggests 
that the primary structure of CaM is conserved to a remarkable degree 
among widely divergent species. A comparison of CaM from diverse 
phylogenetic species and tissues like the muscle of marine 
invertebrates, seal lop and sea anemone and the CaM from skeletal m.uscle 
of rabbit and pig brain by Yazawa et al. (1980) showed highly similar 
structural and functional properties. Davis et al. (1986) purified CaM 
from yeast cells. A comparison of the predicted amino acid sequence of 
yeast CaM showed 607, homology with the sequence of all other known 
CaMs. Ihis homology increased to 80% or more if generally accepted 
conservative amino acid replacements are allowed. Despite its slight 
variation in primary structure, the yeast CaM is 147 residues long and 
nearly identical to its bovine brain counterpart. l"he secondary 
structure as predicted by Chou and Fasman (1978) is similar to the 
predicted structure for mammalian CaM. Because of the conservation of 
its structure, CaM lacks both species and tissue specificity; CaM from 
a unicellular protozoan can activate an enzyme from the bovine brain 
in vitro. 
CALCIUM BINDING - Teo and Wang (1973) first demonstrated that CaM 
binds Ca++. Subsequent studies indicated that the protein binds 4 
Ca++/molecule with high affinity. Most studies have suggested either 
multiple classes of sites for Ca-H- or negative cooperativity (Teo and 
Wang, 1973). In addition, positive cooperativity has recently been 
reported at low Ca++ concentrations. Tlie Kd values obtained are 
— 6 —7 
usually near 10 M (Teo and Wang, 1973). However, lower Kd values (10 
M) have been found at low ionic strength (Wolff et al., 1977). In 
addition, Mg++ (1 mM) decreases the affinity of all sites for calcium 
and Wolff et al. (1977) reported that in the presence of physiological 
-3 
concentration of Mg++ (10 M) and at low ionic strength, CaM binds only 
3 Ca-H-/molecule. Upon binding of Ca-H-, CaM undergoes a large 
conformational change accompanied by a 5-10% increase in alpha-helix 
content as determined by circular dichroism and optical rotatory 
dispersion (Klee, 1977; Dedman et al., 1977). 
CALCIUM BINDING DOMAINS ON CaM - CaM has four putative Ca++ -binding 
sites which fall into two classes differing in their affinity to Ca++ 
(Wolff et al., 1977). Out of the four sites, site 2 and 3 have the 
greatest influence on Ca++ binding, being low and high affinity loci 
for Ca++ respectively (Seamon, 1980). CaM undergoes a well defined 
Ca++ -induced conformational transition (Klee, 1977) and exists in at 
least two defined solution geometries depending on the cytosolic Ca++ 
-7 -5 
concentration ([Ca++] 10 M) or ([Ca-H-] 10 M). Hie change in 
conformation is biologically important since only the Ca-H- -saturated 
form is functionally active (Cheung, 1980; Means et al., 1982). Many 
studies on CaM have dealt with various aspects related to protein-
Ca++ interaction such as affinities of the different binding sites 
(Haiech et al., 1981), conformational changes induced by Ca-H- (Seamon, 
1980) and possible differentiation in number and position of sites 
occupied by Ca+-(- in relation to control of enzyme systems (Burger et 
al., 1983; Kilhoffer et al., 1983). Ca-H- induces the exposure of 
hydrophobic regions of CaM which acts as an interface for interaction 
between CaM and various protein systems, that is in the activation of 
Ca-fH- -CaM dependent enzymes (La Porte et al., 1980). 
In an attempt to understand the nature of Ca-H- binding sites of 
CaM, Buchta et al. (1986) prepared several synthetic peptides 
encompassing the putative Ca+-t- binding sites of CaM. Their findings 
showed that the peptides corresponding to the Ca binding sites 2 and 3 
of CaM can mimic certain features of the parent protein and possess 
some CaM like activity. 
Ca+-i- binding loci have a typical helix-loop-helix structure 
known as the EF hand (Kretsinger, 1975). In the presence of Ca-f-<-, the 
alpha-helix content of CaM as isolated by circular dichroism and 
optical rotatory dispersion is seen to increase from 5-15% to 40-60% 
(Klee, 1977; Liu and Cheung, 1976) and the molecule is transformed 
into a multienzyme activator (Cheung, 1980; Means et al., 1982). X-ray 
crytallographic studies of Ca-H- -saturated CaM have revealed a dumb 
bell like structure in which a long central alf±ia-helix divides the 
molecule into two regions each of which contain a pair of homologous 
Ca++ binding domains and three small alpha-helices (Babu et al.,1985). 
Gariepy et al. (1986) prepared four synthetic peptides corres-
ponding to various CaM residues (9-19), (68-79), (80-92) and 
(141-148). Antisera elicited against the peptides showed stronger 
binding with the apoprotein (CaM in absence of Ca++) than the Ca-f+ 
-saturated form. The structural basis for the Ca-H—induced loss of 
antigenic crossreactivity was sought by reference to the X-ray crystal 
structure of CaM. In presence of Ca-H-, the regions corresponding to 
CaM 9-19, 68-79, 80-92 and 141-148 are solvent exposed and 
alpha-helical (Babu et al., 1985). In the apoprotein, however, the 
crossreactive epitopes of these four regions on CaM are surface 
exposed and hence antigenic. 
MECHANISM OF CALMODULIN ACTION - CaM is a multifunctional protein as 
it activates many enzymes and enzyme systems. The Ca+-f—dependent 
interaction of CaM with the target proteins occurs in two steps; first 
CaM binds Ca-H- according to Equation 1. 
CaM + nCa-H ;?=; CaM. Can++ ;=i- CaM* Ca^ -H-
This interaction apparently occurs in discrete steps. Binding of Ca-H-
is accompanied by a conformational change (indicated by an asterisk). 
The active conformer of CaM then interacts with an enz>Tne which is 
inactive or partially active. The enzyme undergoes a conformational 
change (Liu and Qieung, 1976; Wang et al., 1975; Wolff and Brostrom, 
1976) which, in all cases known so far, is accompanied by activation 
(Enz) according to Equation 2. 
CaM.* Can-H- +Enz = ? (CaM* Can++).Enz :==^ (CaM* Can-H-).Enz* 
The stoichiometry of the active CaM-Ca-H- complex has not yet been 
determined (n can vary between 1 and A) and could vary with different 
CaM-binding proteins. As indicated all steps are reversible. This 
mechanism is shown in Fig. 2. 
CAmODULIN DEPENDENT CELLULAR PROCESSES 
A. Regulation of Cyclic Nucleotide I^ evel - In most tissues CaM is a 
potential regulator of the rate of cyclic nucleotide degradation by 
its action on cyclic nucleotide phosphodiesterase (CNPD) (Wolff and 
Brostrom, 1979; Wang and Waisman, 1979). In brain and C-6 glioma 
cells, it has been reported to stimulate adenylate cyclase and thereby 
modulate cAMP synthesis as well (Brostrom et al., 1975; Cheung et al., 
1975). CaM also influences the synthesis of cGMP as guanylate cyclase 
is also stimulated by Ca-H- (Goldberg and Haddox, 1977). 
1. Activation of CNPD - As first reported by Kakiuchi and Yamazaki 
(1970) only one of the several forms of CNPD is activated by CaM; the 
Ca++-dependent form which has been identified as the soluble, high Km 
enzyme. This enzyme hydrolyses cAMP with a high Km (100 uM) and cGMP 
with a low Km (5-10 uM) (Wells and Hardman, 1977). Activation of CNPD 
by CaM is a reversible, Ca-H—dependent process occuring in two steps 
as described above. The formation of a Ca-H- -dependent complex between 
CaM and CNPD has been demonstrated by gel filtration experiments (Liu 
et al., 1975; Teshima and Kakiuchi, 1974). Under physiological 
conditions, the Ca+-f- threshold for CNPD activation depends on the 
amount of free CaM present. When activation of CNPD is measured at 
binding CaM concentration, the Ca-)~*—dependent data suggest that CaM. 
Figure 2. Schematic Representation of the Hechanism of 
Action of Calmodulin. The binding of four Ca-H-
to calmodulin changes the shape of the protein 
and thereby activates it. The activated calmo-
dulin is able to interact with a receptor 
protein. This interaction changes the protein's 
shape, with the result that it is activated 
(Cheung, 1975). 
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083++ or CaM. Ca^++ is the active species (Wolff et al., 1977). 
2. Activation of adenylate cyclase - In some tissues, a Ca++ stimula-
tion of hormone-dependent adenylate cyclase activity has been reported 
at less than nanomolar Ca++ concentrations (Wolff and Brostrom, 
1979). Brain and C-6 glioma cell adenylate cyclase is also stimulated 
by CaM. Both particulate and detergent solubilised enzymes can be 
reversibly desensitized to Ca-H- -stimulation by removal or addition of 
CaM (Brostrom et al., 1975; Cheung et al., 1975). As with CNPD 
the Ca++ concentration dependence of enzyme stimulation is also 
dependent on CaM concentration which suggests that the mechanism of 
action is similar to that described above (Lynch et al., 1977). The 
formation of a Ca-H—CaM complex was suggested by binding of iodinated 
CaM to synaptosomal membrane (Vandermeers et al., 1978). In the case 
of the C-6 glioma cells, CaM is inhibitory at high concentration and 
the biphasic Ca++-dependent activation curve is shifted to a lower 
range when CaM concentrations are increased (Brostrom et al., 1976). 
Tliese data suggest that Ca++- CaM complex may mediate both activation 
and inhibition of adenylate cyclase. 
B. Regulation of Ca++ Fluxes: 
1. Plasma-membrane Ca++ pumps - CaM not only mediates the effect of 
the Ca++ signal but also regulates its own functioning by controlling 
free cellular Ca++ levels as proposed by Vincenzi (1979). It appears 
to elevate at least two ATP-driven processes responsible for 
controlling cellular concentration of Ca-H-, namely the Ca-H- pump of 
the plasma membrane (Larsen and Vincenzi, 1979) and that of the 
]2 
sarcoplasmic reticuhim (Katz and Remtulla, 1978; Le Peuch et al., 
1979). 
Extrusion of Ca-H- to the extracellular space is accomplished by 
a pump associated with (Ca++-Mg++)-ATPase extensively studied in the 
red blood cell plasma membrane. The mechanism of activation of 
CaM-depleted membrane or solubilised ATPase involves an initial 
formation of the reversible Ca++-CaM complex (Lynch and Cheung, 1979). 
Unlike the interaction of CaM with CNPD,binding to the membrane ATPase 
appears to be favoured by high ionic strength (Farrance and Vincenzi 
1977; Vincenzi and Farrance,1977). The subsequent Ca++-dependent 
activation of the ATPase is due to a 10-fold increase in the Vmax 
value and 2- fold decrease in Km value (Lynch and Cheung, 1979). Ihe 
concentration of CaM needed for half maximal stimulation in the 
presence of saturating levels of Ca-H-, is in the nanomolar range. 
(Ca-H-t—Mg-H-)-ATPase of erythrocyte membrane calcium pump exhibits a 
basal activity of its own. In presence of CaM it is stimulated 2-3 
fold (Bond and Clough, 1973). 
2. Sarcoplasmic reticulum Ca-H- pump - CaM has also been implicated in 
the regulation of Ca-H—transport by cardiac sarcoplasmic reticuluiri 
(Katz and Remtulla, 1978; Le Peuch et al.,1979). Sarcoplasmic (Ca-H-)-
ATPase associated with Ca-H- transport by sarcoplasmic reticulum is 
activated by cAMP-dependent and cAMP independent phosphorylation of 
membrane protein phospholamban (Kirchberger and Tada, 1976). With 
purified sarcoplasmic reticulum membrane, Le Peuch et al., (1979) 
showed that the catalytic subunit of protein kinase and a 
13 
CaH-f—dependent, CaM-dependent kinase associated with the membrane can 
incorporate phosphate into the phospholamban subunit. The 
Ca++-dependent phosphorylation which is totally dependent on CaM 
results in a small but significant increase in Ca-H- transport. 
C. Regulation of Cell Motility; 
1. Activation of myosin kinase - Most eukaryotic cells contain the two 
major proteins responsible for cell motility, actin and myosin (Clark 
and Spudich, 1977). Ttie resulting acto-myosin ATPase is controlled by 
Ca++ levels both in muscle and non muscle cells. CaM mediates 
regulation of both smooth muscle and non muscle contractile proteins. 
Tliese are generally believed to be myosin- linked and regulated by a 
Ca++-dependent, cAMP -independent myosin kinase. This kinase 
specifically phosphorylates a single residue of a regulatory light 
chain of myosin (Pires et al., 1974). The enzyme isolated from smooth 
and skeletal muscle was shown to be composed of 2 subunits, a large 
polypeptide, the apoenzyme and a small regulatory subunit (Yagi et 
al., 1978) which binds Ca-H- (Dabrowska et al.,1978; Yazawa and 
Yagi,1978) and is essential for activity. The Ca-H- binding subunit was 
identified as CaM on the basis of its physicochemical properties and 
its crossreactivity with authentic CaM (Yagi et al., 1978; Dabrowska 
et al.,1978). CaM interacts with the kinase only in the presence of 
Ca-H- in accordance to the mechanism given above. 
2. Stimulation of microtubule disassembly - Microtubules, components 
of the cytoskeleton of the cell are often associated with cellular 
processes involving cell motility. They are believed to be involved in 
u 
chromosomal motion, neurite extension, and axonal transport. The 
congruent localisation of tubulin and CaM during mitosis (Welsh et 
al., 1978; Anderson et al., 1978) suggests a role for CaM in the 
Ca++-dependent disassembly of microtubules (Welsh et al., 1978; Marcum 
et al., 1978). Like other CaM -dependent processes, microtubule 
disassembly depends on the concentration of both Ca++ and CaM in a 
reciprocal fashion (Nishida et al., 1979). 
D. Regulation of Metabolic Pathways - As a mediator of the Ca++ 
signal, CaM ensures the coordinate regulation of metabolic pathways 
associated with Ca-H—dependent function. In skeletal muscle, CaM has 
been shown to regulate the activity of phosphorylase kinase which is 
responsible for glycogen breakdown (Cohen et al., 1978). The 
activation of phosphorylase kinase by CaM is more complex than is the 
regulation of other enzymes hitherto described.Phosphorylase kinase is 
composed of 4 different subunits with an alpha, beta, gamma, delta 
structure. The delta subunit was shown to be CaM (Cohen et al., 1978). 
Phosphorylase kinase is completely dependent on Ca-H- for activity. It 
is now believed that the delta subunit confers Ca-H- sensitivity on the 
enzyme. Indeed Cei-H- binding to the phosphorylase kinase (Kilimann and 
Heilmeyer, 1977) is very similar to Ca++ binding to CaM. In addition, 
the basal Ca-H-dependent activity of phosporylase kinase can be 
increased further if CaM is added to the incubation mixture. 
Finally, in plants CaM has recently been identified as the acti-
vator of an important regulatory enzyme NAD kinase which controls the 
levels of NADP. This is the first report that indicates that Ca-H- may 
,]5 
also act as second messenger in plants (Anderson and Cormier,1978). 
All these functions of calmodulin are summarised in Fig. 3. 
INTERACTION OF CALMODULIN WITH EUKARYOTIC MEM3RANE PROTEIN; 
CaM interacts with components of the RBC membrane cytoskeleton 
as well as with the membrane itself. It has been shown that under 
physiological salt concentrations, CaM shows a Ca++-dependent weak 
interaction with purified spectrin (Berglund et al., 1984; Hussain et 
al., 1984) and isolated membrane skeleton (Burns and Gratzer, 1985). 
On the other band, spectrin like molecules such as brain fodrin, 
intestinal TW 260/240 and avian spectrin have been shown to bind 
readily to CaM. Since the affinity of CaM for spectrin and the 
cytoskeleton is similar and the number of sites for CaM in the 
cytoskeleton corresponds to the concentration of spectrin, it appears 
likely that spectrin constitutes the major binding site for CaM in 
intact cytoskeleton (Stromqvist et al., 1988). 
Berglund et al. (1986) showed in their experiments that about 
1 >uM free Ca++ is required to obtain binding of CaM to spectrin. The 
stoichiometry of the complex was found to be 1:1 (Burns and Gratzer, 
1985; Tsukita et al.,1983). Since the binding and activation of the 
Ca++ pumps by the Ca-H—CaM appear to be slow (Foder and Scharff,1981), 
the Ca++ signal would exist for a finite time before it is removed by 
the activated pump. Thus, a free Ca-H- concentration in the micromolar 
range is likely to be present at certain times in the red cell and 
this would be sufficient to produce maximal binding of CaM to spectrin 
(Berglund et al., 1986). 
Figure 3. Representation of the Various Functions of 
Calmodulin (Cheung, 1975). 
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It should be, however, recognised that the concentration of the 
two proteins in the red cell are high. CaM is present at 2-3 uM 
concentration (Foder and Scharff, 1981; Kakiuchi et al.,1982) and the 
spectrin concentration is in the range of 3 uM (Morrow et al., 1981). 
Consequently, a Ga++ signal could cause about 10% of the spectrin in 
the cell to bind to CaM in spite of the low affinity. 
The spectrin molecule is 100 nm long and flexible, containing 
two antiparallel, non identical subunits of 220 kDa (B) and 240 kDa 
(cc) respectively (Haest, 1982; Gratzer,1983; Marchesi, 1984). The 
binding site for CaM on the avian spectrin and fodrin molecules has in 
all cases been found on a common 240 kDa subunit.(Glenney et al., 
1982). It was reasonable to expect that the CaM binding site in human 
erythrocyte spectrin is also located on the 240 kDa subunit. However, 
available experimental evidence suggests that the binding site is 
present either on the beta-subunit (Sears et al., 1982) or on both 
subunits (Boivin and Galand, 1984). It has been established now that 
both subunits show some tendency to bind, although the beta-subunit 
binds with the greatest affinity. 
In order to understand better the nature of the erythrocyte 
spectrin CaM interaction and to identify the precise CaM binding site 
on the spectrin molecule. Sears et al. (1986) carried out various 
studies. On the basis of their results with peptide mapping they 
concluded that the binding is confined to a very specific region of 
domain 4 (Speicher et al., 1982) of the spectrin beta-subunit as shown 
in Fig. 4. This CaM binding site in erythrocyte spectrin near the 
Figure 4. Schematic Representation of the Calmodulin 
Binding Region ( B-IV domain ) of Human Erythro-
cyte Spectrin (Sears et al., 1986). 
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amino terminus of the beta-subunit may be analogous to the alpha-
subunit CaM binding site identified in the non-erythroid spectrin 
(Palfrey et al., 1982; Harris etal., 1985; Kakiuchi et al., 1981; 
Bartelt et al., 1982; Glenney et al., 1982; Tsukita et al., 1983). 
Sears et al. (1986) also showed that the binding of spectrin to CaM is 
enhanced in presence of urea. The stimulation of binding by urea may 
result from the exposure of hydrophobic sites to Ca-H—CaM complex (Cox 
et al., 1985). 
In the cytoskeleton actin is organised into short protofilaments 
each containing about 12 actin monomers (Pinder and Gratzer, 1983; 
Shen et al., 1986). Recently it was inferred from electron microscopy 
of cytoskeleton (Byers and Branton, 1985; Shen et al., 1986) that each 
actin protofilament is typically associated with 5-8 spectrin 
tetramers. The association between actin filaments and spectrin is 
strengthened by protein 4.1 (Ohanian et al., 1984). Thus, it is seen 
that erythrocyte spectrin in presence or absence of protein 4.1 
(Elbaum et al., 1984; Pinder etal., 1984; Stromqvist et al., 1985) 
influences actin polymerization. 
The domain 4 on the beta subunit of spectrin which binds CaM is 
near the putative sites of protein 4.1 and actin binding (Morrow et 
al., 1980; Tyler et al., 1980). The proximity of CaM binding to the 
end of spectrin molecule involved with actin and protein 4.1 
interaction suggests that such binding may be modulated by CaM 
complexes with spectrin. 
Little is known concerning the functional significance of CaM 
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binding to spectrin. It is seen that CaM-spectrin complex specifically 
depresses the protein 4.1 stimulated actin binding of erythroid 
spectrin when the CciM is not covalently linked. This suppression is 
Ca++ dependent (Anderson and Morrow, 1987) and indicates that Ca++-CaM 
regulates spectrin-actin interaction via a Ca-H—dependent binding of 
CaM to spectrin. CaM also completely inhibits binding of protein 4.1 
independent binding of F-actin in non erythroid spectrin in presence 
of a third unidentified factor (Sobue et al., 1983). Thus it appears 
that CaM down regulates the binding of F-actin to spectrin in a 
fashion antagonistic to the stimulation caused by protein 4.1. 
The spectrin network in the erythrocyte cytoskeleton is an 
important factor for cellular deformability and for maintenance of the 
discocytic shape of the red blood cell (Mohandas and Shohet, 1978; 
Palek and Liu, 1979; Cohen, 1983). A number of protein-protein 
interactions like those of actin-band 4.1, ankyrin-band 3 contribute 
to the dynamic structure of spectrin network (Bennett, 1985). Among 
them CaM is seen to interact with band 4.1 and spectrin and may modify 
the membrane stiffness when it binds with Ca++ (Sobue 1980; Sobue et 
al., 1981; Husain et al., 1985). 
Murakami et al. (1986) showed that cellular deformability gra-
dually decreased with increasing Ca++ content and diamide treatment 
which induces crosslinking of spectrin. This evidence suggests that 
the increase of cellular Ca++ induces changes in the dynamic structure 
of the spectrin network. Iherefore an increase in intracellular Ca++ 
concentration leads to the binding of Ca++ to CaM, which subsequently 
7] 
binds to spectrin and band 4.1, leading to the modification of 
spectrin network in such a way that the membrane stiffness is 
increased. This hypothesis has another line of evidence. It was seen 
by Murakami et al. (1986) that calmodulin inhibitors W-7 and 
Trifluoperazine restore the deformability. 
EXPERIMENTAL 
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MATERIALS 
Chemicals used for the present studies were obtained from the 
sources indicated against their names. Glass distilled water was used 
in all the experiments. 
Chemical Source 
Acrylamide 
Ammonium molybdate 
Ammonium persulfate 
l-Amino-2-naphthol-4-sulfonic acid 
Adenosine-5-triphosphoric acid 
(Disodium salt) 
Bovine serum albumin 
Blue dextran 
Calcium chloride 
Coomassie brilliant blue R-250 
Cytochrome C 
Ethylene glycol-bis-(aminoethylether) 
N,N'-tetracetic acid. 
Ethylene diamine teraacetic acid 
Folin's phenol reagent 
Hemoglobin 
Sigma Chemical Co., U.S.A. 
May and Baker Ltd., England 
May and Baker Ltd., England 
Centron Res. Lab., India 
Loba-Chemie, India 
Sigma Chemical Co., U.S.A. 
Pharmacia Fine Chemicals, 
Sweden 
Sarabhai M. Chemicals, India 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
B.D.H., India 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
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Magnesium chloride 
Marker proteins for SDS-Electrophoresis 
2-Mercaptoethanol 
N,N'-Methylene bisacrylamide 
Magnesium chloride 
Ouabain 
Perchloric acid 
Potassium chloride 
Pyronin Y 
Ribonuclease A 
Sephadex G-lOO 
Sodium acetate 
Sodium bisulfite 
Sodium lauryl sulfate 
Sucrose 
N,N,N',N'-Tetramethyl ethylene diamine 
Tris (hydroxy methyl) amino methane 
Sarabhai M. Chemicals, India 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
B.D.H., India 
Sarabhai M. Chemicals, India 
B.D.H., England 
E. Merck, India 
Sarabhai M. Chemicals, India 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
Pharmacia Fine Chemicals, 
Sweden 
E. Merck, India 
E. Merck, India 
Sigma Chemical Co., U.S.A. 
B.D.H., India 
B.D.H., India 
Sigma Chemical Co., U.S.A. 
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METHODS 
I. PREPARATION OF ERYTHROCYTE GHOSTS AND HEMOLYZATE: 
A. Erythrocyte Ghosts - Fresh blood collected in ACD (acid citrate 
dextrose) from various animal species was used. Outdated human blood 
was obtained from the local blood bank. 
Erythrocyte ghosts were prepared by the method of Fairbanks et 
al. (1971) which is based on the principle of hypotonic lysis, 
described by Dodge et al. (1963). Packed RBGs were washed three times 
in isotonic (154 mM) NaCl and the "buffy coat" was removed by 
aspiration. The washed RBCs were hemolyzed by mixing rapidly 1 ml 
portion of the cells with 40 ml of cold 5 mM Tris-acetate buffer, pH 
7.4. Hie suspension was centrifuged at 12,000 x g for 30 min in a 
refrigerated centrifuge. The resulting deep red supernatant was 
aspirated leaving the red translucent pellet of packed ghosts, over a 
minute, opaque, cream coloured "button". Removal of the latter at this 
stage was essential for minimizing contamination of ghosts with 
proteases. Each centrifuge tube was tilted and rotated to allow the 
loose ghost pellet to slide off the tightly packed button which could 
be then aspirated with little loss of ghosts. After two additional 
washes under similar conditions, the pellet was homogeneous and 
comprised of intact dimpled ghosts. 
B. Membrane-free Hemolyzate - Goat blood collected in freshly prepared 
ACD from the local slaughter house was used. 
Packed RBCs obtained by centrifugation of blood at 1,000 x g 
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for 10 min were washed three times with isotonic (154 mM) NaCl and the 
"buffy coat" was removed by aspiration as described above. The washed 
RBCs were hemolyzed by mixing 1 vol. of the cells with 14 vol.of 20 mM 
Tris-acetate buffer, pH 7.4. The resulting suspension was centrifuged 
at 12,000 X g for 30 min., the membrane pelleted out and the membrane-
free hemolyzate was obtained by careful decantation. 
II. CGLORIMETRIC PROCEDURES: 
A. Protein Estimation - Protein estimation was performed by the method 
of Lowry et al. (1951) using BSA as the standard. Red blood cell 
ghosts were dissolved by mixing with equal vol. of 0.2% SDS. Suitable 
aliquots of the solution were diluted to 1 ml with distilled water. 
To this was added 5 ml of freshly prepared copper reagent (prepared by 
mixing in 1:50 ratio 0.5 % w/v copper sulfate in 1 % sodium-potassium 
tartrate and 2.0 % w/v sodium carbonate in O.IN NaOH) and the tubes 
were incubated at room temperature for 10 min. To each tube was added 
0.5 ml of 1 N Folin-phenol reagent and the tubes were instantly 
vortexed.Absorbance of the developed blue colour was measured after 30 
min at 660 nm against a reagent blank in a Bausch and Lomb spectronic 
20 spectrophotometer. A calibration curve was prepared using BSA 
containing 0.2 % SDS (Haest et al., 1981). For the estimation of other 
proteins, the entire procedure was carried out in absence of SDS. 
B. Assay of ATPase and Calmodulin - ATPase assay was carried out as 
described by Raess and Vincenzi (1980) with slight modifications. 
Assay medium contained in a total volume of 2.0 ml, approximately 
25-250 ug membrane protein; 80 mM NaCl; 15 mM KCl; 3 mM MgCl2; 3 mM 
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ATP; 18 niM Tris-acetate buffer, pH 7.A; 0.1 mM ouabain; 0.1 mM EGTA 
with or without added 0.2 mM CaCl2. 
Membranes were preincubated with the assay mixture lacking ATP 
for approximately 10 min and the reaction was initiated by the 
addition of ATP. Incubation was carried out at 37 C for 50 min. The 
reaction was terminated by addition of 0.5 ml of 1.2 M PCA. The tubes 
were centrifuged and the supernatant was sampled for the release of 
inorganic phosphate by the method of Fiske and Subbarow (1925). 
Inorganic phosphate release was found to be linear with respect 
to time and proportional to the amount of membrane protein added. 
Membranes were usually assayed on the day after preparation. 
Enzyme activities were operationally defined. (Mg++)- ATPase 
was that activity found in the presence of 0.1 mM EGTA and absence of 
added CaCl2 . (Ca-H-Mg-H-)-ATPase was defined as the additional ATP 
splitting obtained upon the addition of CaCl2. (Na+-K+-F^++)-ATPase 
was the activity in absence of ouabain. Basal (Ca++-M^++)-ATPase 
activity was defined as that activity measured in the absence of added 
hemolyzate or calmodulin and activated (Ca-H—Mg++)-ATPase was that 
measured in presence of hemolyzate or calmodulin. The activity of 
calmodulin is the difference between basal and activated 
(Ca++-Mg-H-)-ATPase. Activity of CaM was non -linear with time or with 
increasing concentration. Calmodulin activity was expressed as units 
and each unit represented the amount that stimulated the release of 
one nanomole inorganic phosphate per min under standard conditions. 
C. Estimation of Inorganic Phosphate - The method of Fiske and 
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Subbarow (1925) w^ is used. Suitable aliquots of the sample were diluted 
to 5.0 ml with distilled water. Ihis was followed by addition of 1.0 
ml of 10 N PCA and 1.0 ml of 4 % ammonium molybdate. The solution was 
vortexed and incubated at room temperature for 10 min. To this was 
added 1.0 ml of ANSA reagent (prepared by dissolving 30 g sodium 
bisulfite, 60 g sodium sulfite and 0.5 g ANSA in 250 ml water (Prior 
to use, 10 ml of this stock solution was diluted with distilled water 
to 25 ml). After 20 min, the blue colour was read against a reagent 
blank in a Bausch and Lomb spectronic 20 spectrophotometer at 660 nm. 
III.PURIFK^TION OF CALMODULIN: 
A. Heat Treatment of Hemolyzate - Appropriate volumes of the membrane 
free goat hemolyzate were heated in a boiling water bath for 5 min 
with constant stirring and centrifuged to remove the coagulated 
proteins which were discarded. The supernatant was concentrated and 
used for further treatment. 
B. Gel Filtration Chromatography - A column of Sepadex G-lOO was 
prepared as recommended by Peterson and Sober (1962). Sephadex G-lOO 
was allowed to swell in a suitable amount of distilled water for 5 
hours in a boiling water bath. A previously cleaned glass column was 
mounted vertically and glass wool plugged along with glass beads at 
the bottom of the column. The column was filled to one third of its 
length with the operating buffer (20 mM Tris-acetate, pH 7.4). The 
dearated gel slurry was then gently poured into the column with the 
help of a glass rod. The column was left standing overnight. Flow rate 
was subsequently increased gradually with the help of a stop cock. 
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After accomplishing a constant rate of flow (higher than required for 
final elution) the column was adjusted to the required flow rate. The 
column was thoroughly washed with two bed volumes of operating buffer, 
In order to determine the uniform packing and void volume (Vo) of the 
column, 2.0 ml of 2 % (w/v) blue dextran was passed through the 
column. The buffer was carefully removed from the surface and protein 
sample applied. Ihe volume of blue dextran or protein solution applied 
on the column was not more than 2 - 3 % of the total bed volume of the 
column. 
C. SDS-Polyacrylamide Gel Electrophoresis - SDS-PAGE was performed 
essentially, according to the method of Fairbanks et al. (1971) and 
Davis (1964) using a mini slab gel apparatus manufactured by Atto 
Co., Japan. Concentrated solutions were mixed in the order and 
proportions given in Table 1, to give a final concentration of 15 % 
acrylamide. The cocktail was then poured into the mold formed by two 
glass plates ( 7 x 9 cm) separated by 1.5 mm thick spacer. Bubbles and 
leaks were avoided. A comb providing a template for 12 sample wells 
was inserted into the stacking gel solution before polymerisation 
began. The polymerisation was complete in about 2 hours. The comb was 
removed and the wells thus formed were washed and overlaid with 
distilled water. The samples for electrophoresis were prepared by mix-
ing protein samples with equal vol. of sample buffer and boiling the 
mixture for 3-5 min. 10 ul of protein samples were applied to the 
wells. Electrophoresis was carried out at 50 V for approximately 4 
hours in Tris/EDTA/acetate buffer containing 0.2 % SDS. After the 
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Table 1 
Formulas for Stock Solutions, Buffers and Gels. 
1. 41.5 % stock solution of acrylamide-bis acrylamide -
Acrylamide (40 g) 
bisacrylamide 1.5 g 
Make upto 100 ml with distilled water. 
2. 10 X Buffer -
1.0 M Tris (40 ml) 
2.0 M Sodium acetate (10 ml) 
0.2 M EDTA (10 ml) 
Adjust the pH to 7.4 with glacial acetic acid and make upto 100 
ml with distilled water. 
3. Sample buffer -
2 % SDS 
20 % Sucrose 
2 mM EDTA 
10 mM Tris-HCl (pH 8.0) 
Make upto 100 ml with distilled water. 
4. 20 % SDS 
5. 1.5 % (w/v) Ammonium persulfate solution. 
6. 0.5 % (w/v) TEMED 
7. Electrophoresis buffer -
10 X Buffer (100 ml) 
20 % SDS (10 ml) 
Make upto 1000 ml with distilled water. 
8. Gel Composition (per 10 ml of polymerising solution) -
Components 15 % gel 
Concentrated acrylamide-bis acryla-
mide solution (41.5%) 
Distilled water 
10 X Buffer 
20 % SDS 
0.5 % TEMED 
APS (1.5 %) 
3.75 ml 
3.25 ml 
1.0 ml 
0.5 ml 
0.5 ml 
1.0 ml 
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completion of the; electrophoresis, the gels were immediately subjected 
to fixation and staining with coomassie brilliant blue as described by 
Fairbanks et al. (1971). The gels were treated with staining and 
destaining solutions in the following order. (1) 0.1 % coomassie blue 
R-250 in 25 % isoproj^ anol + 10 % glacial acetic acid for 4 hours, (2) 
Destaining of the gels for several hours with 10 % glacial acetic acid 
until the blue background became clear. 
D. Electroelution - 15 % acrylamide gels were prepared as described 
above. About 10 ul of protein sample (containing about 10 ug of: 
purified calmodulin) was loaded in each well and electrophoresis was 
carried out at 50 V for approximately 4 hours. After electrophoresis, 
the gels were taken out, washed twice with distilled water and 
incubated in 4 M sodium acetate for 6 hours at room temperature. The 
opaque bands wt>re visualised against a white background. Tlie lanes 
containing the oi^ aque bands were sliced transversely (1 cm slices) and 
washed several times in 20 mM Tris-acetate buffer, pH 7.4. Prior to 
electroelution the slices were macerated and homogenised in buffer 
mentioned above. The resulting suspension was taken in a dialysis bag 
and electroelution carried out in the electrophoresis 
buffer(Tris/EDTA/Acetate with 0.2 % SDS) for 2 hours at 50 V at rocm 
temperature. This preparation was centrifuged and the supernatant 
dialyzed overnight against 20 mM Tris-acetate, pH 7.4. Calmodulin 
activity was determined in the dialyzed preparation. Control sample 
consisted of portions of the gel lacking the opaque bands and 
subjected to the treatment mentioned above. 
51 
IV. ESTIMATION OF CALCIUM IN CAIilODULIN: 
The calcium content of calmodulin was determined by a micropro-
cessor controlled GBC double beam atomic absorption spectrometer 
(Model 902). The instrunent was calibrated using a standard calcium 
carbonate solution. The CaM samples were incubated in 2 mM CaCl2for 2 
hours. Incubated samples were dialyzed exhaustively for 24 hours 
against 20 mM Tris-acetate, pH 7.4. Prior to analysis, 2 n]g/ml KCl was 
added to each sample. 
RESULTS 
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I. ISOLATION AND PURIFICATION OF CALMODULIN FROM GOAT RED BLOOD CELLS 
A. Heat Treatment - Goat RBCs washed several times with isotonic NaCl 
were hemolyzed by mixing 1 vol. of cells with 14 vol. of 20 mM 
Tris-acetate buffer, pH 7.4. The hemolyzate .was subjected to 
centrifugation to remove the membrane as described in the text. The 
membrane-free goat hemolyzate thus obtained was heated in a boiling 
water bath. The resulting suspension was centrifuged to remove the 
coagulated protein. The heat treatment resulted in 23 - fold 
purification with 79 % yield.The supernatant was concentrated in air 
and loaded on a Sephadex G-lOO column. 
B. Sephadex G-lOO Gel Filtration - The heat -treated hemolyzate (350 
ml) was concentrated to 3.0 ml by air drying in a dialysis bag. This 
was loaded on a gel filtration column. 20 mM Tris-acetate buffer, pH 
7.4 was used for the elution of the sample. The column was operated at 
a flow rate of 25 ml/hr at room temperature. Fractions were analysed 
for protein by the method of Lowry et al. (1951) and for calmodulin 
activity. 
Figure 5 shows the elution profile of calmodulin on the Sephadex 
G-lOO column. There was present a major and a minor protein peak and 
only the latter contained calmodulin activity. A further 19-fold 
purification was achieved in this step. 
The purification of calmodulin from goat RBCs is summarized in 
Table 2. As shown, the protein was purified 431-fold with a yield of 
about 30 %. 
Figure 5. Sephadex G-lOO Gel Filtration. The supernatant 
of the heat-treated hemolyzate was concentrated 
to 3.0 ml and applied on a Sephadex G-lOO 
column ( 2x70 cms ) previously equilibrated with 
2(>iiN Tris-acetate buffer, pH 7.4. The column 
was eluted with the same buffer and 5.0 ml frac-
tions were collected. All fractions were assayed 
for calmodulin activity and protein content. 
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Table 2 
Purification of Goat RBC Calmodulin. 
Isolation Step Total Activi- Total Prote- Total Specific Yield Fold 
Volume ty Acti- in* Prot- Activity (%) purifi-
vity ein cation 
(ml) (units/ml) (units)(mg/ml) (mg) (units/mg) 
Crude hemoly- 400 10 4000 11.5 4600 0.87 100 1 
zate 
Heat treatment 350 9 3150 0.45 20 157 79 23 
Sephadex G-lOO 40 30 1200 0.08 375 3.2 30 431 
Determined by the procedure of Lowry et al. (1951), 
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II. HOMOGENEITY: 
Homogeneity of calmodulin was determined by polyacrylamide gel 
electrophoresis performed in presence of SDS. The crude hemolyzate 
showed only a single diffused band of hemoglobin in 15 % gel (Figure 
6, Lane A) and upon heat treatment,the hemoglobin band became faint 
and a new band appeared (Lane B). The hemoglobin band disappeared 
after gel filtration on Sephadex G-lOO and a single sharp band was 
obtained (Lane C). 
In order to locate calmodulin activity, the unstained gel was 
incubated in 4 M sodium acetate for 6 hours. The protein bands so 
visualised were sliced and electrically eluted as described in text. 
The dialysed filtrate was used for the determination of calmodulin 
activity. No activity could be detected in other regions of the gel. 
III. PROPERTIES OF PURIFIED CALMODULIN: 
A. Molecular Weight - The molecular weight of the purified calmodulin 
was determined by PAGE performed in the presence of SDS. 
SDS- electrophoresis in presence of 0.2 % SDS revealed a single 
distinct band (Figure 7). The molecular weight of the protein was 
calculated from the mobility of the protein by the procedure reported 
by Weber and Osborn (1969). Ihe mobilities of marker proteins 
determined under identical conditions were plotted against the 
logarithm of molecular weight (Figure 8). Least square analysis of the 
data indicated a linear relationship between Log M and relative 
mobility (Rm). Calmodulin exhibited mobility between trypsin 
inhibitor and oC-lactalbumin suggesting a molecular weight of 
Figure 6, SDS-Polyacrylamide Gel Electrophoresis. The 
electrophoretic pattern of different preparatio-
ns of calmodulin in 15 % gels are shown. 10 ug 
of each preparation was electrophoresed on the 
slab gel at 50 V at room temperature. 
Lane A - Crude hemolyzate 
Lane B - Heat-treated fraction 
Lane C - Sephadex G-lOO fraction 
^ ^ 
A B C 
Figure 7. SDS- Polyacrylamide Gel Electrophoresis of the 
Purified Calmodulin. The procedure described by 
Fairbanks et al.(1971) was followed.The purified 
calmodulin (15 ug) was subjected to electropho-
resis in 15 % gels containing 0.2 % SDS. Prior 
to electrophoresis,the protein was denatured by 
heating at 100 C for 5 min with sample buffer 
containing 2-mercaptoethanol. A mixture of 
marker proteins was also electrophoresed under 
identical conditions. 
Lane A - Mixture of marker proteins 
Lane B - Calmodulin 
B 
Figure 8. Calibration Curve for the Determination of 
Molecular Weight of Calmodulin. The calibration 
curve was obtained by plotting Log M versus Rm 
on SDS-polyacrylamide gel. The molecular weight 
of calmodulin was determined from this curve. 
1. Bovine serum albumin (66 kDa) 
2. Egg albumin (45 kDa) 
3. Glyceraldehyde-3-phosphate dehydrogenase 
(36 kDa) 
4. Carbonic anhydrase (29 kDa) 
5. Trypsinogen (24 kDa) 
6. Trypsin inhibitor (20.1 kDa) 
7. cC -Lactalbumin (14.2 kDa) 
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about 15.5 kDa. 
B. Effect of Calmodulin on Various Human RBC Membrane ATPases - Ihe 
activities of (Mg++)-ATPase, (Na+-K+-Mg-H-)-ATPase and (Ca++-Mg++)-
ATPase present in human RBC membrane were determined as described in 
the text in absence as well as presence of CaM. 50 ug of purified 
CaM was used to observe the stimulatory effect. (Mg-H-)-ATPase and 
(Na+-K+-Mg-H-)-ATPase were uneffected while (Ca++- Mg-H-)- ATPase was 
stimulated about 3- fold as shown in Table 3. 
4 0 
Table 3 
Effect of Calmodulin on Various Human RBC Membrane ATPases. 
ATPase activity (units) 
-Calmodulin +Calmodulin % Stimulation 
(Mg-H-)-ATPase 
( Na+-K+-Mg-H-)-ATPase 
(Ca-H-Mg-H-)-ATPase 
1.6 
4.2 
11.0 
1.6 
4.2 
34.0 
Nil-
Nil 
309 
The amount required to release one nanomole Pi/min under standard 
assay conditions. 
* * • 
50 ug of purified CaM used to observe stimulation. 
DISCUSSION 
4] 
Excellent information is available on the structure and function 
of human erythrocyte membrane (Haest, 1982; Bennet, 1985). The 
information on membranes of other mammals is, however, very limited. 
Tlie available data shows interesting evolutionary adaptations in 
various species. Sheep and the closely related goat have small RBCs 
which are triangular/irregular in shape (Farooqui et al., 1987). These 
cells characteristically lack phosphatidyl choline and are very rich 
in sphingomyelin (White, 1973). Several important Ca-H- -mediated/ 
stimulated processes are lacking in these cells; for instance, the 
sheep RBCs do not exhibit Ca++ -mediated shape changes (Eaton at al., 
1977). Allan and Michell (1977) have demonstrated that the Ca++ 
-induced phosphoinositide phosphodiesterase is completely absent in 
the sheep RBCs. In addition, it was not possible to demonstrate Ca-H-
-induced membrane phosphorylation in the sheep RBCs. More recently, 
Farooqui et al. (1987) have shown that the goat RBCs are completely 
refractive to Ca++ and phosphate -induced fusion. 
Ca++ have been shown to play a very important role in the 
aging and the senescence of the human RBC membrane. RBCs maintain very 
low intracellular Ca++ levels (10 -lO^M) (Lorand and Conrad, 1984) and 
accumulation of high Ca-H- results in stimulation of several enzymes. 
The (Ca-H- -Mg-i-t-)-ATPase which constitutes the Ca-H- -pump is activated 
in presence of Ca-H and extrudes out the intracellular Ca-H- (Larsen 
and Vincenzi, 1979). In case of goat and sheep, this enzyme shows very 
low activity (Vincenzi, 1981). When high concentrations of Ca-i-+-
accumulate in the human RBC, the result is cell senescence. The 
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senescent cells are taken up by the reticulo-endothelial cells of 
spleen and liver. Increase in Ca++ also decreases intracellular ATP 
levels and brings atout echinocyte formation (Quist, 1980). In 
addition, Ca++ stimulate transglutaminases (Lorand and Conrad, 1984). 
Transglutaminase mediated cross-linking of the RBC membrane 
polypeptides has been shown to result in very marked increase in the 
cell rigidity and their phagocytosis. Ca-H- have also been shown to 
promote lipid peroxidation (Jain and Hochstein, 1980). More recently, 
Wang et al. (1988) have shown that a small increase in intracellular 
Ca-H- stimulates erythrocyte calpain which in turn stimulates Ca++ 
-dependent ATPase activity and decreases its sensitivity to 
calmodulin. At high concentration, however, the calpain inactivated 
the (Ca-H- -Mg-H-)-ATPase activity very markedly. Based on these 
observations, it appeared very clear that Can- do play a key role in 
the aging and senescence of human RBC. Lack of several Ca+-f- -mediated 
processes in goat and sheep RBCs was examined in this laboratory. It 
was shown that the goat and sheep RBCs lack both the Ca-H- -dependent 
proteolytic and transglutaminase activities (Khan and Saleemuddin, 
1988). Since several Ca-H- -mediated processes including the 
(Ca-H-Mg-H)-ATPase, adenylate cyclase, phosphodiesterase and probably 
transglutaminase (Puszkin et al., 1982) operate via calmodulin, it was 
of interest to examine if the goat RBCs contain calmodulin and if this 
calmodulin differs significantly from that of human and other 
mammalian RBC calmodulins. A preliminary report indicated that goat 
RBCs do exhibit significant calmodulin activity (Vincenzi, 1981). No 
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further information is available on the nature of the goat and sheep 
RBC calmodulin. 
Goat RBC membrane exhibits very low (Ca-H—Mg++)-ATPase activity 
but high calmodulin activity as reported by Vincenzi (1981). In 
studies conducted on goat RBC membrane, the activity of (Ca++-Mg++)-
ATPase was found to be extremely low. Therefore, in order to assay 
goat calmodulin, human RBC membranes were used as a source of 
(Ca-H—Mg++)-ATPase. Isolated human RBC membranes show significant 
basal activity in absence of calmodulin (Larsen and Vincenzi, 1979). A 
marked stimulation of the basal activity of human (Ca-H—Mg++) -ATPase 
was observed using goat calmodulin thus confirming the earlier reports 
of calmodulin lacking species specificity (Cheung, 1980). 
A 200 % stimulation of the basal (Ca-H-Mg-H-) -ATPase activity 
was seen in this study using crude hemolyzate. This was in accordance 
with the results of Bond and Clough (1973) who reported 250% 
activation at the highest concentration of hemolyzate used. With 50 ug 
of purified calmodulin added to the assay medium, the stimulation 
increased to 309%. Gopinath and Vincenzi (1977) had earlier reported 
370% activation over the basal activity of human (Ca-H—Mg-H-)-ATPase 
using human erythrocyte calmodulin. Jarrett and Penniston (1977) also 
reported 240% activation by hemolyzate and 300% activation by purified 
calmodulin. 
Numerous attempts have been made during the last several years 
to isolate and purify calmodulin from various sources. The 
purification procedure employed here yielded 431- fold purified 
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calmodulin with an yield of about 30% (Table 2). The scheme is simple 
and accomplished in two steps. In the first step, the membrane-free 
goat hemolyzate is heated to 100 C in a boiling water bath for 5 min 
in view of the known thermal stability of calmodulin (Au and Lee, 
1978). While hemoglobin and other proteins are denatured and 
coagulated by this treatment, calmodulin remained in solution and 
retained its activity. There is some loss in activity, however, as 
given in Table 2. This may be either due to the denaturation or loss 
of a fraction of calmodulin during filtration following the heating 
procedure. The volume of the hemolyzate also decreases considerably as 
shown in Table 2. A boiling procedure was used by Au (1978) to isolate 
(Ca-H—Mg-H-)-ATPase activator from pig erythrocytes and separated it 
from (Ca-H—Mg-H-)-ATPase inhibitor which is heat labile. Likewise, 
Gopalakrishna and Anderson (1982) utilised a heat denaturation step to 
purify calmodulin from bovine brain. The heating step was, however, 
used by these workers after isoelectric precipitation of brain 
homogenate at pH 4.3. This method allowed 70-80% recovery of 
calmodulin while removing 70% of contaminating proteins. The heating 
step used in the present study resulted in 23- fold purification with 
an yield of 79 %. 
The second step of purification involved the fractionation of 
the concentrated supernatant on a Sephadex G-lOO column. This 
step resulted in complete purification of calmodulin. A further 
19-fold purification was achieved in this step (Fig 5). Luthra et al. 
(1976) partially purified the (Ca-H-Mg-H-)-ATPase activator from 
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human erythrocyte, membrane-free hemolyzate by using Ql-Sephadex C -50,. 
The hemoglobin remained bound to the column while calmodulin passed 
through and was collected in the flow through. This procedure, 
however, resulted only in partial purification. Jarrett and Penniston 
(1977) passed the post CM-Sephadex preparation through a DEAE-
cellulose column. The electrophoretic studies of the column fractions, 
however, showed more than one protein band. A single band with 
molecular weight less than 20 kDa whose presence coincided with the 
active fractions was predominant. Jarrett and Penniston in the 
following year (1978) were able to completely purify calmodulin from 
human RBCs. Ttie procedure used by them was a rather elaborate 4- stop 
scheme which involved DEAE cellulose batch absorption, gel filtration 
on Sephadex G-lOO, a second DEAE -cellulose column chromatography and 
lastly an ammonium sulfate precipitation step. 
The homogeneity of the preparation prepared in the course of the 
present studies was established by the appearance of a single protein 
band in the gel filtration fractions and in 15% slab gels using 
SDS-PAGE (Fig.6). Such a high acrylamide concentration was used 
keeping in mind the small size of the calmodulin molecule. 
Electroelution of the single band in unstained gels gave calmodulin 
activity which further confirmed the homogeneity of the preparation. 
Luthra et al. (1976) had reported the molecular weight of 
calmodulin to be below 50 kDa. In the subsequent years, various 
studies using sedimentation equilibrium, SDS-gel electrophoresis, gel 
filtration chromatography have given molecular weight values in the 
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range of 15-19 kDa in both the presence and absence of Ca-H-. The 
molecular weight of calmodulin based upon its amino acid composition 
is 16.7 1<DQ (Watterson et al., 1980), based on sedimentation equilib-
rium data is 18.7 kDa (Klee et al., 1980) and 15 kDa (Lin et al., 
1974) SDS-PAGE conducted by Klee et al. (1979) gave a molecular weight 
of 16.5 kDa. The molecular weight of CaM as determined by SDS-PAGE in 
this study gave a value of 15.5 kDa (Fig. 8). Thus, their is remarka-
ble agreement in molecular weight values as determined by various 
methods. 
Experiments were conducted on purified CaM to see its effect on 
three different ATPases viz. (Ca++-Mg++)-ATPase, (Na-H-K+-Mg++)-ATPase 
and (Mg-H-)-ATPase present in human RBC membranes. Bond and Clough 
(1973) in their very early studies on RBC CaM had reported that CaM 
present in crude form in human RBC hemolyzate was unable to stimulate 
(Mg-H-)-ATPase and (Na-H-K+-Mg++)-ATPase. This showed that CaM is a 
specific activator of (Ca++-Mg++)-ATPase. Gopinath and Vincenzi (1977) 
in their work, found no effect of calmodulin on (Mg++)-ATPase from 
human RBCs. Similar experiments conducted by Halloran et al. (1980) on 
(Mg-H-)-ATPase and (Na+-K+-Mg++)-ATPase of rat RBC membrane showed no 
stimulation by CaM in crude or purified form. Our data on goat RBC CaM 
supports these observations fully (Table 3). 
The goat RBC • calmodulin also appears to be identical with the 
other calmodulins (Vincenzi, 1981; Klee et al., 1980) in its ability 
to bind calcium. It was calculated from atomic absorption data that 
approximately 4 atoms of Ca++ bound to 1 molecule of calmodulin. 
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Tliese studies indicate that goat RBC calmodulin is not signifi-
cantly different from that occurring in RBCs and other tissues of 
other mammals. lack of the Ca++ -mediated effects in goat RBCs, 
therefore, may not be related to a defective or abnormal calmodulin. 
SUMMARY 
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In view of the lack of several Ca-H- -mediated processes in goat 
and sheep red bood cell membranes, it was considered of interest to 
investigate if these cells contain adequate calmodulin activity and if 
the calmodulin behaved differently from that derived from human and 
other mammalian red blood cells. 
Goat red blood cell calmodulin was purified to homogeneity using 
membrane-free hemolyzate. The purification scheme was a simple 2-step 
procedure involving heating of the membrane-free hemolyzate in a 
boiling water bath for 5 min as the first step. Over 96 % of the 
contaminating proteins (mostly hemoglobin) were removed in this step 
and resulted in 23-fold purification with an yield of 79 %. The 
supernatant of this step was concentrated in air and loaded on a 
Sephadex G-lOO column equilibrated with 20mM Tris-acetate buffer, pH 
7.4 which gave a further 19-fold purification. The fractions with high 
calmodulin activity gave, on sodium dodecyl sulphate -polyacrylamide 
gel electrophoresis, a single protein band, thus confirming the 
homogeneity of the preparation. This procedure resulted in a 431-fold 
purification with an yield of 30 %. 
Several studies were performed with the purified calmodulin. The 
molecular weight as determined by sodium dodecyl sulphate 
-polyacrylamide gel electrophoresis, gave a value of 15.5 kDa. Studies 
on the effect of calmodulin on various human red blood cell membrane 
ATPases showed that (t1g++)-ATPase and (Na+-K+-Mg-H-;-ATPase remain 
unaffected while (Ca+-i—Mg-H-)-ATPase undergoes a 3-fold stimulation 
indicating the specificity of calmodulin. Determination of the Ca++ 
content of calmodulin by atomic absorption spectrometer, showed that 
each molecule of calmodulin binds 4 atoms of Ca-H-, under saturating 
conditions. 
BIBLIOGRAPHY 
49 
Allan, D. and Michell, R.H. (1977) Biochem. J. 232, 43. 
Anderson, B., OstxDrn, M., Weber, K. (1978) Cytobiologie Eur. J. 
Cell. Biol. j7, 354. 
Anderson,J.M., Cormier, M.J. (1978) Biochem. Biophys. Res. Commun. 
_84, 595. 
Anderson, J.P. and Morrow, J.S. (1987) J. Biol. Chem. 262, 
6365. 
Au, K.S. and Lee, CM. (1978) Int. J. Biochem. _9^  339. 
Au, K.S. (1978) Int. J. Biochem. 9, 477. 
Babu, Y.S., Sack, J.S., Greenhough, T.J., Bugg, C.E., Means, A.R. 
and Cook, W.J. (1985) Nature 315, 37. 
Bartelt, D.C., Carlin, R.K., Scheele, G.A. and Cohen, W.D. (1982) 
J. Cell Biol. _95, 278. 
Bennett, V. (1985) Ann. Rev. Biochem. 54, 273. 
Berglund, A., Backman, L. and Shanbhag, V.P. (1984) FEBS Lett. 
172, 109. 
Berglund, A., Backman, L. and Shanbhag, V.P. (1986) FEBS Lett. 
201, 306. 
Berridge, M.J. (1975) Adv. Cyclic Nucleotide Res. 6, 1. 
Boivin, P. and Galand, C. (1984) Biochem. Int. _8, 23. 
Bond, G.H. and Clough, D.L. (1973) Biochim. Biophys. Acta 323, 
592. 
Brostrom, CO. and Wolff, D.J. (1974) Arch. Biochem. Biophys. 165, 
715. 
Brostrom, CO., Huang, Y.C, Breckenridge, B.M. and Wolff, D.J. 
(1975) Proc. Natl. Acad. Sci. USA, _72, 64. 
Brostrom, M.A., Brostrom, CO., Breckenridge, B.M. and Wolff, D.J. 
(1976). J. Biol. Chem. _251, 4744. 
Buchta, R., Bondi, E. and Fridkin, M. (1986) Int. J. Peptide 
Protein Res. 28, 289. 
Burger, D., Stein, E.A. and Cox, J.A. (1983) J. Biol. Chem. 258, 
14733. 
50 
Burns, N.R. and Gratzer, W.B. (1985) Biochemistry^, 3070. 
Byers, T.J., and Branton, D. (1985) Proc. Natl. Acad. Sci. USA, 
_82, 6153. 
Cheung, W.Y. (1970) Biochem. Biophys. Res. Commun. 38, 533. 
Cheung, W.Y. (1975) Sci. Amer. _232, 48. 
Cheung, W.Y., Bradman, L.S., Lynch, T.J., Lin, Y.M. and Tallant, 
E.A. (1975) Biochem. Biophys. Res. Commun. 66, 1055. 
Cheung, W.Y. (1980) Science^, 19. 
Childers, S.R. and Siegel, F.L. (1975) Biochim. Biophys. Acta 405, 
99. 
Chou, P. and Fasman, G.D. (1978) Adv. Enzymol. _47, 45. 
Clark, M. and Spudich, J.A. (1977) Ann. Rev. Biochem. ^ , 797. 
Cohen, P., Burchell, A., Foulkes, J.G., Cohen, P.T.W., Vanaman, 
T.C. and Nairn, A.C. (1978) FEBS Lett. _92, 287. 
Cohen, CM. (1983) Semin. Hematol. 20, 141. 
Cox, J.A., Comte, M., Fitton, J.E. and De Grado, W.F. (1985) J. 
Biol. Chem. ^ , 2527. 
Dabrowska,R., Sherry, J.M.F., Aroraatorio, D.K. and Hartshorne, D.J. 
(1978) Biochemistry 2Z) 253. 
Davis, B.J. (1964) Ann. NY Acad. Sci. ^ 21, 404. 
Davis, T.N., Urdea, M.S., Masiarz, F.R., Thorner, J. (1986) Cell 
47, 423. 
Dedman, J.R., Potter, J.D., Jackson, R.L., Johnson, J.D., Means, 
A.R. (1977) J. Biol. Chera. Z52, 8415. 
Dodge, J.T., Mitchell, C. and Hanahan, D.J. (1963) Arch. Biochem. 
Biophys., ^ 00, 119. 
Eaton, J.W., Burger, E., White, J.G. and Nelson, D. (1977) in 
Erythrocyte Membranes: Recent Clinical and Experimental Advances 
(Kruckeberg, W.C, Eaton, J.W. and Brewer, A.J., eds) p. 37, Liss, 
A.R. Inc., New York. 
E^rie, J.C., Campbell, J.A. Flangas, A.L. and Siegel, F.L. (1977). J. 
Neurochem. 28, 1207. 
Elbaum, D., Mimms, L.T. and Branton, D. (1984) Biochemistry 23, 
4813. — 
Fairbanks, G., Steck, T.L. and Wallach, D.F.M. (1971) Biochemistry, 
10, 2606. 
Farooqui, S.M., Wall, R.K., Baker, R.F. and KaIra, V.K. (1987) 
Biochim. Biophys. Acta 904, 239. 
Farrance, M.L.. and Vincenzi, F.F. (1977) Biochim. Biophys. Acta 
471, 49. 
Fiske, CM., Subbarow, Y. (1925) J. Biol. Chem. 66, 375. 
Foder, B. and Scharff, 0. (1981) Biochim. Biophys. Acta 649, 367. 
Gariepy, J., Mietzner, T.A. and Schoolnik, G.K. (1986) Proc. Natl. 
Acad. Sci. USA., 83, 
Glenney, J.R., Jr., Glenney, P. and Weber, K. (1982) Proc. Natl. Acad. 
Sci. USA. _79, 4002. 
Goldberg, N.D. and Iladdox, M.K. (1977) Ann. Rev. Biochem. 46, 823. 
Gopinath, R.M. and Vincenzi, F.F. (1977) Biochem. Biophys. Res. 
Commun. 77, 1203. 
Gopalakrishna, R. and Anderson, W.B. (1982) Biochem. Biophys. Res. 
Commun. _104, 830. 
Gratzer, W.B. (1983) Muscle Nonmuscle Motil. 2, 37. 
Haest, C.W.M., Kamp, D. and Deuticke, B. (1981) Biochim. Biophys. 
Acta, 643, 319. 
Haest, C.W.M. (1982) Biochim. Biophys. Acta 694, 331. 
Haiech, J., Klee, C.B. and Demaille, J.G. (1981) Biochemistry 20, 
3890. ~~ 
Halloran, B.D., De Luca, H.F. and Vincenzi, F.F. (1980) FEBS Lett. 
114, 89. 
Harris, A.S., Green, L.A.D., Ainger, K.J. and Morrow, J.S. (1985) 
Biochim. Biophys. Acta 830, 147. 
Husain, A., Howlett, G.J. and Sawyer, W.H. (1984) Biochem. Biophys. 
Res. Commun. ^ 22, 1194. 
Husain, A., Howlett, G.J. and Sawyer, W.H. (1985) Biochem. Int. 10, 1. 
52 
Jackson, R.L., Dedman, J.R., Schreiber, W.E., Bhatnagar, P.K., Knapp, 
R.D. and Means, A.R. (1977) Biochem. Biophys. Res. Commun. 77, 723. 
Jain, S.K. and Hochstein, P. (1980) Biochem. Biophys. Res. Commun. 
92, 247. 
Jarrett,H.W., Penniston, J.T. (1977) Biochem. Biophys. Res. Commun. 
^ , 1210. 
Jarrett, H.W. and Penniston, J.T. (1978) J. Biol. Chem. _253, 4676. 
Jones, H.P., Bradford, M.M., Mc Rorie, R.A. and Cormier, M.J. (1978) 
Biochem. Biophys. Res. Commun. 82, 1264. 
Kakiuchi, S., Yamazaki, R. and Nakajima, H. (1970) Proc. Jpn. Acad, 
46, 587. 
Kakiuchi,S. and Yamazaki, R. (1970) Biochem. Biophys. Res. Commun. 41, 
1104. ~ 
Kakiuchi, S., Sobue, K. and Fujita, M. (1981) FEBS Lett. 132, 
144. 
Kakiuchi, S., Yasuda, S., Yamazaki, R., Teshima, Y., Kanda, K., 
Kakiuchi, R. and Sobue, K. (1982) J. Biochem. _92, 1041. 
Katz, S. and Remtulla, M.A. (1978) Biochem. Biophys. Res. Commun. 
83, 1373. 
Kilimann, M. and Heilmeyer, L.M., Jr. (1977) Eur. J. Biochemistry. 
13, 191. 
Kilhoffer, H.C., Haiech, J. and Demaille, J.G. (1983) Mol. Cell. 
Biochem. 51, 33. 
Kirchberger, M.A. and Tada, M. (1976) J. Biol. Chem. _251, 725. 
Khan, M.T. and Saleemuddin, M. (1988) Biochim. Biophys. Acta 940, 
165. 
Klee, C.B. (1977) Biochemistry J^, 1017. 
Klee, C.B., Crouch, T.H., Krinks, M.H. (1979). Proc. Natl. Acad. Sci. 
USA. 26, 6270. 
Klee, C.B., Crouch, T.H. and Richman, P.G. (1980) Ann. Rev. Biochem. 
49, 489. 
Kretsinger, R.H. and Barry, CD. (1975) Biochim. Biophys. Acta 405, 
40. 
53 
Kretsinger, R.H. (1975) in Calcium Transport in Contraction and 
Secretion (Carafoli, E., Clementi, F., Drabikowski, W., Margreth, 
A., eds.) p 469, North Holland Publishing Co., Amsterdam. 
Kretsinger, R.H. (1977) in Calcium Binding Proteins and Calcium 
functions (Wasserman et al., eds.) p 63, Elsevier, New York, and North 
Holland. 
Kuznicki, J., Kuznicki, L. and Drabikowski, W. (1979) Cell Biol. Int. 
Rep. 3, 17. 
Larsen, F.L. and Vincenzi, F.F. (1979) Science 204, 306. 
La Porte, D.C., Wierman, B.M. and Storm, D.R. (1980) Biochemistry 19, 
3814. ~ 
Le Peuch, C.J. Haiech, J. and Demaille, J.G. (1979) Biochemistry, 18, 
5150. ~ 
Lin, Y.M., Liu, Y.P. and Cheung, W.Y. (1974). J. Biol. Chem. 249, 
4943. 
Lin, Y.M., Liu, Y.P. and Cheung, W.Y. (1975) FEES Lett. 49, 356. 
Liu, Y.P. and Cheung, W.Y. (1976) J. Biol. Chem. 25]., 4193. 
Lorand, L. and Conrad, S.M. (1984) Mol. Cell. Biol. 58, 9. 
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) 
J. Biol. Chem., 193_, 265. 
Luthra, M.G., Hildenbrandt, G.R. and Hanahan, D.J. (1976) Biochim. 
Biophys. Acta 419, 164. 
Lynch, T.J., Tallant, E.A. and Cheung, W.Y. (1977) Arch. Biochem. 
Biophys. 182_, 124. 
Lynch, T.J. and Cheung, W.Y. (1979) Arch. Biochem. Biophys. 194, 
165. 
Manalan, A.S. and Klee, C.B. (1984) Calmodulin Adv. Cyclic 
Nucleotide Protein Phosphorylation Res. 18, 227. 
Marches!, V.T. (1984) Prog. Clin. Biol. Res. 159, Erythrocyte 
Membranes 3, 1. 
Marcum, J.M., Dedman, J.R., Brinkley, B.R. and Means, A.R. (1978) 
Proc. Natl. Acad. Sci. USA. 2^, 3771. 
Means, A.R., Tash, J.S. and Chafouleas, J.G. (1982) Physiol Rev. 62,1. 
54 
Miyake, M. and Kakiuchi, S. (1978) Brain Res. 139, 378. 
Mohandas, N. and Shohet, S.B. (1978) Current Topic Hematol. 1, 
71. 
Morrow, J.S., Speicher, D.W., Knowles, W.J., Hsu, J.C. and 
Marchesi, V.T. (1980) Proc. Natl. Acad. Sci. USA 2^, 6592. 
Morrow, J.S., Haigh, W.B., Jr. and Marchesi, V.T. (1981) J. Supramol. 
Struct. Cell Biochem. j7, 257. 
Murakami,J., Maeda, N., Kon, K. and Shiga, T. (1986) Biochim. Biophys. 
Acta 863, 23. 
Nishida, E., Kumagai, H., Ohtsuki, I. and Saki, M. (1979) J. Biochem. 
85, 1257. 
Ohanian, V., Wolfe, L.C, John, K.M., Pinder, J.C, Lux, S.E. and 
Gratzer, W.B. (1984) Biochemistry, 23, 4416. 
Palek, J. and Liu, S.C. (1979) Semin. Hematol. _16, 75. 
Palfrey, M.C., Schiebler, W. and Greengard, P. (1982) Proc. Natl. 
Acad. Sci., USA 2?, 3780. 
Peterson, E.A. and Sober, H.A. (1962) in Method. Enzymol., 
(Colowick, S.P. and Kaplan, N.O., eds.). Vol. 5, p. 3, Academic 
Press, New York. ~ 
Pinder, J.C. and Gratzer, W.B. (1983) J. Cell. Biol. 96, 768. 
Pinder, J.C, Ohanian, V. and Gratzer, W.B. (1984) FEBS Lett. 169, 
161. 
Pires, E., Perry, S.V. and Thomas, M.A.W. (1974) FEBS Lett. 41, 
292. ~ 
Puszkin, E.G., Raghuraman, V., Jenkins, C.S.P. and Grosman, L. 
(1982) Fed. Proc. _41. 1235 (Abstr. 5637). 
Quist, E.E. (1980) Biochem. Biophys. Res. Commun. _92, 631. 
Raess, B.U. and Vincenzi, F.F. (1980) J. Pharmacol. Methods _4^ 391. 
Sears, D.E., Morrow, J.S. and Marchesi, V.T. (1982) J. Cell. Biol. 
95, 251 (abstr.) 
Sears, D.E., Marchesi, V.T. and Morrow, J.S. (1986) Biochim. Biophys. 
Acta 870, 432. 
55 
Seamon, K.B. (1980) Biochemistry jL9, 207. 
Shen, B.W., Josephs, R. and Steck, T.L. (1986) J. Cell. Biol. 102, 
997. 
Smoake, J.A., Song, S.Y. and Cheung, W.Y. (1974) Biochim. Biophys. 
A c t a ^ , 402. 
Sobue, K., Fujita, M. and Muramoto, Y. (1980) Biochem. Int. 1, 561. 
Sobue, K., Muramoto, Y. Fujita, M. and Kakiuchi, S. (1981) Biochem. 
Biophys. Res. Coramun. 100, 1063. 
Sobue, K., Kanda, K., Adachi, J. and Kakiuchi, K. (1983) Proc. Natl. 
Acad. Sci. USA_80, 6868. 
Speicher, D.W., Morrovs?, J.S., Knowles, W.J. and Marchesi, V.T. (1982) 
J. Biol. Chem. 2_57^  9093. 
Stevens, F.C., Walsh, M., Ho, H.C., Teo, T.S. and Wang, J.H. (1976) J. 
Biol. Chem. ^ , 4495. 
Stromqvist, M., Backman, L. and Shanbhag, V.P. (1985) FEES Lett. 190, 
15. 
Stromqvist, M., Berglund, A., Shanbhag, V.P. and Backman, L. (1988) 
Biochemistry 27, 1104. 
Teo, T.S., Wang, T.H. and Wang, J.H. (1973) J. Biol. Chem. 248, 588. 
Teo, T.S. and Wang, J.H. (1973) J. Biol. Chem. _248, 5950. 
Teshima. Y. and Kakiuchi, S. (1974) Biochem. Biophys. Res. Commun. 56, 
489. ~ 
Teshima, Y. and Kakiuchi, S. (1978) J. Cyclic Nucleotide Res. 4, 219. 
Tsukita, S., Tsukita, S., Ishikawa, H., Kurokawa, M., Morimoto, K., 
Sobue, K. and Kakiuchi, S. (1983) J. Cell Biol. _97, 574. 
Tyler, J.M., Reinhardt, B.N. and Branton, D. (1980) J. Biol. Chem. 
255, 7034. 
Vandermeers, A., Robberecht, P., Vandermeers-Piret, M.C., Rathe, J., 
Christophe, J. (1978) Biochem. Biophys. Res. Commun. 84, 1076. 
Vincenzi, F.F. and Farrance, M.L. (1977) J. Supramol. Struct. 7, 301. 
Vincenzi, F.F. (1979) Proc. West Pharmacol. Soc. 22, 289. 
56 
Vincenzi, F.F. (1981) in "Ihe Red Cell Fifth Ann Arbor Conference", 
p 363, Liss, A.R. Inc., New York. 
Vogt, H.P., Strassburger, W., Wollmer, A., Fieischhauer, J., Bullard, 
B. and Mercola, D. (1979) J. Theor. Biol. 76, 297. 
Waisman, D.M., Stevens, F.C. and Wang, J.M. (1975) Biochem. Biophys. 
Res. Commun. 65^ , 975. 
Wang, J.H., Teo, T.S., Ho, H.C. and Stevens, F.C. (1975) Adv. Cyclic 
Nucleotide Res. 5_, 179. 
Wang, J.H. and Waisman, D.M. (1979) Curr. Top. Cell. Regul. _15, 47. 
Wang, K.K.W., Villalobo, A. and Roufogalis, B.D. (1988) Arch. Biochem. 
Biophys. 260, 696. 
Watterson, D.M., Haercloson, W.G., Keller, P.M., Sharief, F. and 
Vanaman, T.C. (1976) J. Biol. Chem. 251., 4501. 
Watterson, D.M., Sharief, F., Vanaman, T.C. (1980) J. Biol. Chem. 255, 
962. 
Weber, K. and Osborn, M. (1969) J. Biol. Chem. 244, 4406. 
Wells, J.N. and Hardman, J.G. (1977) Adv. Cyclic Nucleotide Res. 8, 
119. 
Welsh, M.J., Dedman, J.R., Brinkley, B.R. and Means, A.R. (1978) Proc. 
Natl. Acad. Sci. USA _75, 1867. 
Wliite, D.A, (1973) in "Form and Function of Phospholipids" (Ansell, 
B., Dawson, R.M.C. and Hawthorae, J.N., eds.), p 454, Elsevier, 
Amsterdam. 
Wolff, D.J. and Brostrom, CO. (1976) Arch. Biochem. Biophys. 173, 
720. 
Wolff, D.J., Poirier, P.G., Brostrom, CO. and Brostrom, M.A. (1977) 
J. Biol. Chem. 252, 4108. 
Wolff, D.J. and Brostrom, CO. (1979) Adv. Cyclic Nucleotide Res. 11, 
27. ~ 
Yagi, K., Yazawa, M., Kakiuchi, S., Oshima, M. and Uenishi, K. (1978) 
J. Biol. Chem. 251, ^^^^• 
Yazawa, M. and Yagi, K. (1978) J. Biochem. _84, 1259. 
Yazawa, M., Kuwayama, H. and Yagi, K. (1978) J. Biochem. ^ , 1253. 
Yazawa, M., Sakuma, M. and Yagi, K. (1980) J. Biochem. 87, 1313. 
